Back to News
Market Impact: 0.2
Sino Biopharmaceutical Limited - Depositary Receipt Consensus Price Target Decreased by 15.14% to $21.83
Source: Nasdaq
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
The average one-year price target for Sino Biopharmaceutical Limited’s depositary receipt was revised down 15.14% to $21.83 per share from $25.72, an estimate dated October 22, 2026. The article provides no further detail on the revision or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?